About Marathwada Pharma Cluster
Data last updated:
Marathwada Pharma Cluster is a private not for profit company based in Aurangabad, Maharashtra, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 31 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U91100MH2015NPL267041.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Vijay Barasu Khachane and Anil Moreshwar Save.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Plot No 321 Sector – C N – 1 Cidco, Aurangabad, Maharashtra, India – 431003.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adorapharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No 321 Sector – C N – 1 Cidco, Aurangabad, Maharashtra, India – 431003
- IndustryHealthcare, Preventive Health Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Marathwada Pharma Cluster FY 2023 filings available
Marathwada Pharma Cluster reported revenue of ₹70 for FY 2022.
Compounded Annual Growth Rate (CAGR) of Marathwada Pharma Cluster
Revenue has declined at a compounded annual rate (CAGR) of 77% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Marathwada Pharma Cluster
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Marathwada Pharma Cluster
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Marathwada Pharma Cluster are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Marathwada Pharma Cluster
Marathwada Pharma Cluster is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bargad Hospitals Private Limited | ₹80 (FY 2024) | •••• | •••• | •••• | Sagar, Madhya Pradesh, India | |
| Indian Spa and Wellness Association | ₹80 (FY 2022) | •••• | •••• | •••• | Navi Mumbai, Maharashtra, India | |
| Om Sai Medicare Trade & Services Private Limited | ₹80 (FY 2023) | •••• | •••• | -98.0% | •••• | Mumbai, Maharashtra, India |
| Ashesh Health Foundation | ₹74 (FY 2025) | •••• | •••• | -57.0% | •••• | New Delhi, Delhi, India |
| Harbhajan Singh Yogi Clinic Private Limited | ₹71 (FY 2023) | •••• | •••• | -100.0% | •••• | Delhi, India |
| Marathwada Pharma Cluster this company | ₹70 (FY 2022) | •••• | •••• | •••• | Aurangabad, Maharashtra, India | |
| Wintrobe Healthcare Private Limited | ₹50 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| Foresight Group of Medical and Education Research | ₹48 (FY 2020) | •••• | •••• | -100.0% | •••• | Raipur, Chhattisgarh, India |
| Impact Healthconsultant Private Limited | ₹40 (FY 2025) | •••• | •••• | -100.0% | •••• | New Delhi, Delhi, India |
| Frontenders Health Management Private Limited | ₹35 (FY 2022) | •••• | •••• | -99.0% | •••• | Chennai, Tamil Nadu, India |
| JJ Wellness Network Private Limited | ₹16 (FY 2024) | •••• | •••• | -99.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Marathwada Pharma Cluster by revenue in the Healthcare industry (Preventive Healthcare Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Marathwada Pharma Cluster
Marathwada Pharma Cluster is audited by AGRAWAL SONIGARA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AGRAWAL SONIGARA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Marathwada Pharma Cluster
Marathwada Pharma Cluster has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Barasu Khachane | Director | 31 Jul 2015 | 11 Years 2 Months | Current |
| Anil Moreshwar Save Also directs: Savera Pharmaceuticals Private Limited, Atra Labs Private Limited | Director | 31 Jul 2015 | 11 Years 2 Months | Current |
| Anand Devidasrao Nagapurkar Also directs: Adora Products Private Limited | Director | 31 Jul 2015 | 11 Years 2 Months | Current |
| Sanjay Shivnarayan Toshniwal | Director | 31 Jul 2015 | 11 Years 2 Months | Current |
Ownership and Shareholding of Marathwada Pharma Cluster
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Marathwada Pharma Cluster
Marathwada Pharma Cluster does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Marathwada Pharma Cluster
Employment history and EPFO contributions of people linked to Marathwada Pharma Cluster.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Marathwada Pharma Cluster
Marathwada Pharma Cluster has 4 board changes on record since 2015: 4 appointments. The latest: Anand Devidasrao Nagapurkar was appointed as Director on 31 Jul 2015.
Credit Ratings, Litigation & Regulatory Alerts for Marathwada Pharma Cluster
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Marathwada Pharma Cluster
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Marathwada Pharma Cluster
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Marathwada Pharma Cluster
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Marathwada Pharma Cluster
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Marathwada Pharma Cluster
Marathwada Pharma Cluster is an active private not for profit company based in Aurangabad, Maharashtra, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 31 July 2015 (11+ years old) and is registered under CIN U91100MH2015NPL267041.
Marathwada Pharma Cluster has 4 current directors:
- Vijay Barasu Khachane - Director
- Anil Moreshwar Save - Director
- Anand Devidasrao Nagapurkar - Director
- Sanjay Shivnarayan Toshniwal - Director
The CIN (Corporate Identification Number) of Marathwada Pharma Cluster is U91100MH2015NPL267041. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Marathwada Pharma Cluster was incorporated on 31 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Marathwada Pharma Cluster by revenue are Bargad Hospitals Private Limited, Indian Spa and Wellness Association, Om Sai Medicare Trade & Services Private Limited, Ashesh Health Foundation, Harbhajan Singh Yogi Clinic Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Services).
Anand Devidasrao Nagapurkar was appointed as Director on 31 Jul 2015. Anil Moreshwar Save was appointed as Director on 31 Jul 2015. Sanjay Shivnarayan Toshniwal was appointed as Director on 31 Jul 2015. Marathwada Pharma Cluster has 4 board changes on record in total.
Marathwada Pharma Cluster can be reached through the website adorapharma.co.in. Its registered office is in Aurangabad, Maharashtra, India.
The registered office of Marathwada Pharma Cluster is at Plot No 321 Sector – C N – 1 Cidco, Aurangabad, Maharashtra, India – 431003.
Marathwada Pharma Cluster has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Marathwada Pharma Cluster operates in the healthcare industry, in the preventive health services segment.
No. Marathwada Pharma Cluster is not listed on any stock exchange. It is an unlisted company.